Search
for
Sort by
Research 511–540 of 1000+
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge
- Effects of a cyclosporine-based protocol in canine granulomatous sebaceous adenitis - case series
- Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results
- Teriflunomida and hair disorders
- Tether-induced tenosynovitis: The importance of an intact skin barrier
- Targeting nonmelanoma skin cancer using selective photothermolysis with 595 nm pulsed dye laser: Outcomes of 1080 cases
- 270 A novel small compound HPH-15 antagonizes TGF-β/Smad signaling and ameliorates experimental skin fibrosis
- 267 Deep phenotyping of patients with xeroderma pigmentosum and trichothiodystrophy
- Subject Index
- Dissecting the microenvironment around biosynthetic scaffolds in murine skin wound healing
- Optimization of Ultrasonic-Assisted Extraction of Total Saponins from<i>Eclipta prostrasta</i>L. Using Response Surface Methodology
- Introducing Platelet-Rich Stroma: Platelet-Rich Plasma (PRP) and Stromal Vascular Fraction (SVF) Combined for the Treatment of Androgenetic Alopecia
- Reply to ‘Frontal fibrosing alopecia’
- Reassessing frontal fibrosing alopecia
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Emerging treatments in alopecia
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
- The effect of plasma rich in growth factors combined with follicular unit extraction surgery for the treatment of hair loss: A pilot study
- Adverse cutaneous effects of psychotropic medications
- Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Mechanism of PPARα agonist in alopecia areata
- Current systemic treatment strategies for hidradenitis suppurativa
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Scalp Bacterial Microbiota Dysbiosis in Androgenetic Alopecia: Community Structure, Functional Profiles, and Associations with Lifestyle Factors
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA